PembrolizumabImmune-related pneumonitis and immune-related polyneuropathy: 2 case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2021年 / 1836卷 / 1期

关键词：

D O I：

10.1007/s40278-021-88461-4

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：642 / 642

相关论文

共 50 条

[1] PembrolizumabImmune-related pneumonitis: case report
[J]. Reactions Weekly, 2020, 1828 (1) : 412 - 412
[2] PembrolizumabImmune-related pneumonitis: case report
[J]. Reactions Weekly, 2017, 1679 (1) : 153 - 153
[3] PembrolizumabImmune-related pneumonitis: case report
[J]. Reactions Weekly, 2020, 1815 (1) : 271 - 271
[4] PembrolizumabImmune-related hepatitis and immune-related pneumonitis following off-label use: 2 case reports
[J]. Reactions Weekly, 2021, 1875 (1) : 283 - 283
[5] Immunosuppressants/pembrolizumabImmune-related hepatitis, immune-related retinopathy and lack of efficacy: case report
[J]. Reactions Weekly, 2023, 1958 (1) : 281 - 281
[6] Camrelizumab/doxorubicin/pembrolizumabImmune-related pneumonitis: 2 case reports
[J]. Reactions Weekly, 2020, 1798 (1) : 70 - 70
[7] PembrolizumabImmune-related hepatitis: case report
[J]. Reactions Weekly, 2023, 1946 (1) : 456 - 456
[8] PembrolizumabImmune-related colitis: case report
[J]. Reactions Weekly, 2018, 1721 (1) : 236 - 236
[9] PembrolizumabImmune-related myelitis: case report
[J]. Reactions Weekly, 2023, 1965 (1) : 399 - 399
[10] PembrolizumabImmune-related hepatitis: case report
[J]. Reactions Weekly, 2022, 1902 (1) : 357 - 357

← 1 2 3 4 5 →